** Shares of health insurer Cano Health CANO.N down 16.6%
at $1.31 before the bell
** Co sees 2023 revenue between $3.10 and $3.25 billion,
below analysts' expectations of $3.25 billion at midpoint -
Refinitiv
** CANO reported Q4 revenue of $680.4 million, better than
analysts' expectations of $654.5 million
** Co posts Q4 loss of 61 cents per share on GAAP basis
** Three of 11 brokerages rate the stock "buy" or higher, 6
rate it "hold" and 2 rate it "sell"; their median PT is $4
** As of last close, CANO up ~15% so far this year
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))